Bioptimus

Bioptimus is a biotechnology company based in Paris, France, focused on developing multi-scale artificial intelligence (AI) foundation models for biology. Founded by experts from institutions like Google DeepMind and Novartis, the company aims to enhance biological research by integrating various biological data, from molecules to whole organisms, into comprehensive AI models. The flagship product, H-Optimus-0, is recognized as the world's largest foundation model for pathology. It excels in predicting gene expression from morphological data and accurately subtyping diseases, such as ovarian cancer. Bioptimus's models combine data modalities like imaging and genetics, facilitating a holistic understanding of complex biological systems. This innovative approach supports applications in drug discovery, disease outcome prediction, and the design of targeted therapies. Bioptimus collaborates with pharmaceutical companies, academic institutions, and the broader scientific community to advance research and innovation in biomedicine. The company is led by CEO Jean-Philippe Vert and has a strong leadership team with expertise in computational biology and AI-driven drug discovery.

Research Paris, France ~2 employees

Work at Bioptimus in HR or recruiting? Claim this page

Employees
2
0% in the 3 months to Jun 2025
12-month attrition
0%
H1B sponsor
NA

Headcount trend

Bioptimus went from 0 employees in Jul 2023 to 2 in Jun 2025.

Headcount data through Jun 2025

Org structure

Headcount by department

Other2

Peer reviews

Worked with someone at Bioptimus?

Anonymous peer reviews on OffTheRecord

Read or write a review

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.